BioMar Group A/S (CPH:BIOMAR)
| Market Cap | 12.17B |
| Revenue (ttm) | 17.44B +4.9% |
| Net Income | 916.00M +35.7% |
| EPS | 9.15 +35.6% |
| Shares Out | 100.23M |
| PE Ratio | 13.26 |
| Forward PE | 13.10 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 50,423 |
| Open | 120.90 |
| Previous Close | 121.00 |
| Day's Range | 119.90 - 123.70 |
| 52-Week Range | 102.00 - 137.00 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 143.80 (+18.45%) |
| Earnings Date | Nov 3, 2026 |
About BioMar Group
BioMar Group A/S provides feeding solutions in the aquaculture industry in Denmark. It operates through four segments: Salmon, Shrimp, Selected Species, and Tech Solutions. The company develops, produces, and delivers feeding solutions for species, such as salmon, shrimp, sea bass, sea bream, trout, turbot, and sturgeon to farmers. It also offers aquaculture feed solutions for Atlantic and Pacific salmon, warm-water shrimp, and other special species. In addition, the company provides AI-based technology solutions for aquacultural feeding and fa... [Read more]
Financial Performance
In 2025, BioMar Group's revenue was 16.53 billion, a decrease of -0.49% compared to the previous year's 16.62 billion. Earnings were 714.00 million, an increase of 5.78%.
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for BIOMAR stock is "Buy." The 12-month stock price target is kr 143.80, which is an increase of 18.45% from the latest price.
News
BioMar Group Earnings Call Transcript: Q3 2026
Q3 volume rose 5%, revenue 19% and EBIT 50% YoY, with record 27.1% ROIC. FY revenue and EBIT guidance increased, while volume expectations softened on temporary market and weather disruptions.
BioMar Group Quarterly report: Q3 2026
BioMar Group has published its Q3 2026 quarterly earnings report on November 3, 2026.
BioMar Group Slides: Q3 2026
BioMar Group has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 3, 2026.
BioMar Group Earnings Call Transcript: Q3 2026
Q3 delivered record feed volumes, 50% EBIT growth and 27% ROIC, prompting higher FY EBIT guidance despite lower volume guidance. Near-term Ecuador power constraints and rising alternative ingredient costs may temper Q4 growth and margins.
BioMar Group Quarterly report: Q3 2026
BioMar Group has published its Q3 2026 quarterly earnings report on November 3, 2026.
BioMar Group Slides: Q3 2026
BioMar Group has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 3, 2026.
BioMar Group Earnings Call Transcript: Q2 2026
Q2 delivered record EBITDA, 23.2% ROIC and strong feed growth, prompting higher FY volume, EBIT and revenue guidance. Biological volumes remain the main risk, while marine-ingredient scarcity is being managed through formulation and sourcing.
BioMar Group Slides: Q2 2026
BioMar Group has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 13, 2026.
BioMar Group Quarterly report: Q2 2026
BioMar Group has published its Q2 2026 quarterly earnings report on August 13, 2026.
BioMar Group Earnings Call Transcript: Q2 2026
Q2 2026 saw strong feed volume and EBIT growth, driven by shrimp and new contracts, despite raw material volatility and IPO costs. Guidance for volume, EBIT, and revenue was raised, with Ecuador and China expansions progressing and most new capacity pre-sold.
BioMar Group Quarterly report: Q2 2026
BioMar Group has published its Q2 2026 quarterly earnings report on August 13, 2026.
BioMar Group Slides: Q2 2026
BioMar Group has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 13, 2026.